Markets Gone Wild

Checkpoint Therapeutics Announces FDA Filing Acceptance of Biologics License Application for Cosibelimab in Metastatic Understanding the Prescription Drug User Fee Act (“PDUFA”) Goal Date On January 3, 2024, the Prescription Drug User Fee Act (“PDUFA”) goal date for Cosibelimab in Metastatic will mark a significant milestone for Checkpoint Therapeutics, Inc. The FDA has indicated that…

Increasing Interest towards Vehicle Automation to Drive the Driver Assistance System Market New York, US, March 02, 2023 (GLOBE NEWSWIRE) — Market Research Future (MRFR) Report Overview: According to a detailed research report by Market Research Future (MRFR), the Driver Assistance System Market is expected to witness significant growth in the coming years. The report…

Deutsche Börse’s cash markets turnover drops 35% YoY but strengthens slightly on monthly basis in February Trading volumes on Börse Frankfurt In February 2023 came in at €2.93 billion, down from €3.01 billion in January 2023. Equities on Deutsche Börse generated € 96.93 billion last month, while trading in ETFs/ETCs/ETNs accounted for €14.84 billion of…

Option Care Health Announces Pricing of Secondary Offering of 13,000,000 Shares of Common Stock and Common Stock Repurchase BANNOCKBURN, Ill., March 01, 2023 (GLOBE NEWSWIRE) — Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell…

Oh No, Another Shareholder Alert! Here we go again, folks. It seems like every other day there is news about yet another company being investigated for claims of wrongdoing. This time, it’s CVRx, Inc. (NASDAQ: CVRX) in the hot seat. According to a recent press release from Pomerantz LLP, they are looking into allegations involving…

BLRX DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important March 6 Deadline in Securities Class Action – BLRX Background Information NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioLineRx Ltd. (NASDAQ:…

Understanding the Investigation: Wayfair Inc. and Shareholder Claims Introduction Attention all shareholders of Wayfair Inc.! The Pomerantz Law Firm is currently conducting an investigation on behalf of investors regarding claims against the company. If you are invested in Wayfair Inc. (NYSE: W), it is advised that you contact Robert S. Willoughby at [email protected] or call…

ROSEN, A TOP RANKED LAW FIRM, Encourages Inspirato Incorporated Investors to Secure Counsel Before Important Deadline in Securities Cla… New York, March 01, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Inspirato Incorporated (NASDAQ: ISPO) between May 11, 2022 and December 15, 2022,…